As of August 28, 2026, Purple Biotech Ltd (PPBT) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Purple Biotech Ltd has a market capitalization of $2.79M, 1.86B shares outstanding, 2 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PPBT.
Market Data
Market Cap$2.79M
Shares Outstanding1.86B
FloatN/A
Cash$6.43M
Debt$184.0K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 98.0% shares (2026Q1 vs prior)
2 institutional holders · 17.2K shares
#1
MORGAN STANLEY
17.2K shares
#2
DANSKE BANK A/S
4 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest10.5K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track PPBT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PPBT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.